SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Guidance II -- Ignore unavailable to you. Want to Upgrade?


To: 2MAR$ who wrote (1794)10/22/2013 10:21:30 PM
From: 2MAR$  Respond to of 2077
 
NUS 112... hits 52-week high after results, guidance top estimates
Shares of global direct selling company Nu Skin Enterprises (NUS) hit a new 52-week high after beating third quarter estimates and raising its full year guidance. WHAT'S NEW: This morning, Nu Skin reported Q3 EPS of $1.80 and revenue of $927.6M against analysts’ consensus views of $1.41 and $798.2M. The company forecast Q4 EPS of $1.85-$1.90, and revenue of $1.02B-$1.05B. Analysts’ consensus estimates were $1.63 and $899.1M, respectively. The company raised it fiscal 2013 guidance for both sales and profit. Nu Skin now expects to generate revenue of $3.18B-$3.21B this fiscal year, which is up from its prior view of $2.91B-$2.95B.

WHAT'S NOTABLE: On the company's earnings conference call, CEO Truman Hunt previewed that on Thursday, at the company's global sales convention,....Nu Skin will initiate a new long-term sales goal. The company will challenge its sales force to grow sales to $10B per year by 2020, according to Hunt, which compares to its prior $5 billion a year sales goal...... PRICE ACTION: In afternoon trading, Nu Skin rose 5.3% to $108.14. Earlier in the session the stock made a fresh 52-week high of $119.46 and the stock is up nearly 200% year to date given today's advance.

OTHERS TO WATCH: Others in the direct selling space include Herbalife (HLF), Avon Products (AVP) and Amway.